Adverse Outcomes Associated With Corticosteroid Use in Critical COVID-19: A Retrospective Multicenter Cohort Study

Corticosteroid is commonly used to reduce damage from inflammatory reactions in coronavirus disease 2019 (COVID-19). We aim to determine the outcomes of corticosteroid use in critically ill COVID-19 patients. Ninety six critically ill patients, hospitalized in 14 hospitals outside Wuhan from January...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Med (Lausanne)
Autori principali: Li, Yichen, Li, Jie, Ke, Jia, Jiao, Na, Zhu, Lixin, Shen, Lihan, Chen, Lei, Jiang, Zhiqiang, Cheng, Sijing, Huang, Yibo, Zou, Yifeng, Zhu, Ruixin, Yan, Guangjun
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2021
Soggetti:
Medicine
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7900536/
https://ncbi.nlm.nih.gov/pubmed/33634148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2021.604263
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi